REGN SignalReason for this trade
1: Market is taking pullback from trendline
2: market is near high supply area
629.22MXN
67.15 BMXN
222.80 BMXN
105.09 M
About REGENERON PHARMACEUTICALS INC
Sector
CEO
Leonard S. Schleifer
Headquarters
Tarrytown
Website
Employees (FY)
13.45 K
Founded
1988
ISIN
US75886F1075
FIGI
BBG00BNKGPS2
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where REGN is featured.
Frequently Asked Questions
The current price of REGN is 15 794.33 MXN — it hasn't changed in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange REGENERON PHARMACEUTICALS INC stocks are traded under the ticker REGN.
REGENERON PHARMACEUTICALS INC is going to release the next earnings report on May 2, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for REGENERON PHARMACEUTICALS INC has a max estimate of 19 803.46 MXN and a min estimate of 11 992.01 MXN.
REGN earnings for the last quarter are 202.02 MXN whereas the estimation was 186.19 MXN which accounts for 8.50% surprise. Estimated earnings for the next quarter are 182.26 MXN. See more details about REGENERON PHARMACEUTICALS INC earnings.
REGENERON PHARMACEUTICALS INC revenue for the last quarter amounts to 58.61 B MXN despite the estimated figure of 56.34 B MXN. In the next quarter revenue is expected to reach 55.96 B MXN.
Yes, you can track REGENERON PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
Like other stocks, REGN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade REGENERON PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 13.45 K employees. See our rating of the largest employees — is REGENERON PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. REGENERON PHARMACEUTICALS INC EBITDA is 79.86 B MXN, and current EBITDA margin is 36.36%. See more stats in REGENERON PHARMACEUTICALS INC financial statements.